General Information of Drug (ID: DMCEXTL)

Drug Name
AdV-tK
Indication
Disease Entry ICD 11 Status REF
Ankylosing spondylitis FA92.0 Phase 2 [1]
Cross-matching ID
TTD ID
D05PGM

References

1 ClinicalTrials.gov (NCT00589875) Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02). U.S. National Institutes of Health.